Click here for Analysts' Upgrades, Downgrades.

Editor's Note: Green and red arrows refer to intraday stock price movement.



) --

Alimera Sciences

(ALIM) - Get Report

price target cut at Citi to $12 from $15 after FDA did not approve lluvien NDA. Maintain Buy rating.


(GOOG) - Get Report

target increased at Kaufman to $690. Company should benefit from strong domestic online holiday sales.



estimates, target raised at Wedbush. Shares of ROVI now seen reaching $59, according to Wedbush Securities. Estimates also increased, to match the company's new guidance, following the SNIC acquisition.

Time Warner Cable


target boosted at Argus to $75. Company is leveraged to benefit from a recovery in the economy. Buy rating.

This article was written by a staff member of TheStreet.